$64.44 -0.46 (-0.71%) AbbVie Inc - New York Stock Exchange, Inc.

Jul. 28, 2016 | 01:25 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 64.44
Trade Time: Jul 28 01:25 PM Eastern Daylight Time
Change: -0.46 (-0.71%)
Prev Close: 64.90
Open: 64.79
Bid: 64.44
Ask: 64.45
  1. Investing Action Plan: Apple, Facebook, Amazon, Big Oil, Boeing, Fed

    Investors Business Daily | Jul. 23, 2016 | 08:00AM EST
  2. 5 Big Drugmakers Reporting Earnings Next Week

    Investors Business Daily | Jul. 22, 2016 | 13:57PM EST
  3. John Paulson Bulks Up Health Care Bet

    GuruFocus | Feb. 17, 2016 | 17:02PM EST
  4. Gilead, Johnson & Johnson or Roche?

    GuruFocus | Feb. 11, 2016 | 12:15PM EST
  5. IPO Indexes Weak, But A Few Leaders Outperform

    IBD | Feb. 10, 2016 | 16:42PM EST
  6. The Generic Drug Battle

    Benzinga | Feb. 10, 2016 | 09:13AM EST
  7. Schoenebaum: Biotech P/Es Show 'Buying Signal' With Caveat; Amgen, Biogen, Celgene & Gilead Have Catalysts

    Benzinga | Feb. 8, 2016 | 15:27PM EST
  8. Benzinga's Top Initiations

    Benzinga | Feb. 5, 2016 | 09:32AM EST
  9. Is Big Pharma Hinting At A SMID-Cap Biotech Rally?

    Benzinga | Feb. 3, 2016 | 13:16PM EST
  10. Earnings Recap For January 29

    Benzinga | Jan. 29, 2016 | 17:36PM EST
  11. Biogen Drug 'Increasingly Vulnerable,' Analyst Warns After Speaking With MS Expert

    Benzinga | Jan. 29, 2016 | 09:29AM EST
  12. AbbVie Falling After Q4 Report, 2016 Guidance Affirmation

    Benzinga | Jan. 29, 2016 | 08:14AM EST
  13. Earnings Scheduled For January 29, 2016

    Benzinga | Jan. 29, 2016 | 04:05AM EST
  14. Abbvie Announces Venetoclax Receives 3rd Breakthrough Therapy Designation from the FDA

    Benzinga | Jan. 28, 2016 | 04:29AM EST
  15. US Big Pharma: What To Watch For In Q4 Results

    Benzinga | Jan. 25, 2016 | 11:16AM EST
Trading Center